Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model

<div>Representative radiograph from a mouse in each group over the study period.</div>

BioMed Research International

fig4

Figure 4

Figure 4: Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents <i>Staphylococcus aureus</i> Infection in an Open Fracture Animal Model 

Figure 4 | Controlled Release of Vancomycin and Tigecycline from an Orthopaedic Implant Coating Prevents Staphylococcus aureus Infection in an Open Fracture Animal Model 